News & Events

Barbara Nelsen Moderates Investment Panel

On Tuesday, October 10, Destination Medical Center (DMC) will bring together investors and innovators from around the state for the 2017 Discovery Square Investors and… Read more

Nelsen Bio At Fall Industry Events

Nelsen Biomedical is pleased to announce that they will attend three cell and gene therapy conferences this fall and moderate two panel discussions focused on… Read more

Nelsen Bio Publishes A New Paper On CAR-T

Four years after Emily Whitehead was treated with chimeric antigen receptor T (CAR-T) cell therapy for acute lymphoblastic leukemia (ALL), she remains cancer free. With… Read more

Nteresting Links